Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216073
Status:
TERMINATED
Last Update Posted:
2011-05-02
First Post:
2005-09-09
Brief Title:
Capecitabine Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
Sponsor:
Hoosier Cancer Research Network
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HOG BRE03-61
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoosier Cancer Research Network
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Kathy Miller MD
Old Organization:
Hoosier Oncology Group
Collaborators
| Name | Class |
|---|---|
| Walther Cancer Institute | OTHER |
| Sanofi | INDUSTRY |
| Hoffmann-La Roche | INDUSTRY |